Jump to content




2 replies to this topic

#1 Rob73


    Junior Member

  • Members
  • Posts & Likes
    Posts: 37
    Likes: 0
About Me
  • Joined: 21-May 09

Posted 09 June 2010 - 02:09 PM

Cosmo’s CB-03-01 phase II pilot study in acne demonstrates superiority over Retin A®

Lainate, Italy – 11 December 2009 – Cosmo Pharmaceuticals S.p.A. (“Cosmo”) (SIX: COPN) announced today positive results in a phase II pilot study of its novel topical anti-androgen 1% cream, CB-03-01. The preliminary data of the trial showed that CB-03-01 met all clinical end points and was clinically superior to placebo and to Retin-A® in the treatment of facial acne vulgaris after 8 weeks of drug application. The detailed clinical report will be available in a few weeks.

CB-03-01 is a new steroid proprietary to Cosmo with anti-androgenic and anti-inflammatory properties; the compound is intended to be indicated for the topical treatment of skin disorders influenced by androgens including acne and potentially, hirsutism or androgenetic alopecia.

This phase II pilot study was designed as a three arm, randomized, double-blind, parallel-groups, controlled study versus placebo and versus Retin-A® 0.05% cream, in facial acne vulgaris.

More info in the full article:

#2 wishfulthinkin



  • Veteran Members
  • Posts & Likes
    Posts: 511
    Likes: 1
About Me
  • Gender:Female
  • Location:Canada
  • Joined: 24-May 05

Posted 28 June 2010 - 10:26 AM

Do you know if this drug is available? Or what it's called?

#3 Maelstrom21


    New Member

  • Members
  • Posts & Likes
    Posts: 13
    Likes: 0
About Me
  • Joined: 16-September 06

Posted 16 October 2010 - 10:11 AM


Seems like it's progressing.

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users